AMP SCZ® Observational Study: PREDICT-DPACC
The Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) is a large international
collaboration to develop algorithms using a set of clinical and cognitive assessments,
multi-modal biomarkers, and clinical endpoints that can be used to predict the trajectori...
Age: 12 - 30 years
Gender: All
Salsa for Schizophrenia: A Feasibility Study
Seeking Research Participants with Schizophrenia or Schizoaffective Disorder for Salsa Dancing Study
We are currently looking for individuals with a diagnosis of schizophrenia or schizoaffective disorder. The purpose of the study is to understand how individuals with sc...
Age: 18 - 65 years
Gender: All
Improving Cognition Via Exercise in Schizophrenia
People with schizophrenia display a broad range of cognitive impairments that have been identified as major determinants of poor functioning and disability. Also, people with schizophrenia are at increased risk for suicide, with approximately 40-50% of individuals attem...
Age: 18 - 55 years
Gender: All
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
Social cognition impairment is critical to the pathology and morbidity of a number of
psychiatric disorders, including the schizophrenia spectrum, the autism spectrum and the
personality disorders, thus representing a dimension consistent with RDoC. As such, this
stu...
Age: 18 - 65 years
Gender: All